Amedisys Stock Target Price and Analyst Consensus
| AMED Stock | USD 94.95 0.54 0.57% |
The current analyst and expert consensus on Amedisys is Buy with 6 hold recommendations. The current projected Amedisys target price consensus is 96.10 with 10 analyst opinions. One of the most common ways Amedisys analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Amedisys vendors, executives, and/or customers. Amedisys recommendation module provides expert sentiment on the projected Amedisys target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Amedisys to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Lowest Forecast 87.45 | Highest Forecast 106.67 | Target Price 96.1 |
Amedisys |
It's important to approach Amedisys' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Amedisys Target Price Consensus
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Amedisys target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Amedisys' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 10 | Buy |
Most Amedisys analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Amedisys stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Amedisys, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAmedisys Target Price Projection
Amedisys' current and average target prices are 94.95 and 96.10, respectively. The current price of Amedisys is the price at which Amedisys is currently trading. On the other hand, Amedisys' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Amedisys Target Price
Amedisys Analyst Ratings
Amedisys' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Amedisys stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Amedisys' financials, market performance, and future outlook by experienced professionals. Amedisys' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Amedisys price targets
Amedisys' stock target price is an estimate of its future price, usually made by analysts. Using Amedisys' target price to determine if it is a suitable investment can be done through the following steps:- Look at Amedisys' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Amedisys' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Amedisys Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Amedisys is a key component of Amedisys valuation and have some predictive power on the future returns of a Amedisys.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Amedisys' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Baby Boomer Prospects Invested over 40 shares | |
 | Hedge Favorites Invested few shares | |
 | Disruptive Technologies Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Social Domain Invested few shares | |
 | Momentum Invested few shares | |
 | Banking Invested over 20 shares | |
 | SRI Sustainable Growth Invested few shares | |
 | FinTech Invested over 40 shares | |
Check out Macroaxis Advice on Amedisys to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stocks Directory Find actively traded stocks across global markets |
The data published in Amedisys' official financial statements usually reflect Amedisys' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Amedisys. For example, before you start analyzing numbers published by Amedisys accountants, it's critical to develop an understanding of what Amedisys' liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of Amedisys' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amedisys' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Amedisys' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amedisys. Please utilize our Beneish M Score to check the likelihood of Amedisys' management manipulating its earnings.